|
Index
|
Cut-off
|
|---|
|
Cost: 75%
|
Cost: 25%
|
|---|
|
Deviance: overall model
|
|
p value
|
< 0.001
|
< 0.001
|
|
VIF
|
|
Broad adherence score
|
|
1
|
Secondary prevention
|
1.0364
|
1.0906
|
|
2
|
Rehabilitation intensity
|
1.2010
|
1.0462
|
|
3
|
Guidance
|
1.0196
|
1.0140
|
|
4
|
PDC
|
1.1190
|
1.0890
|
|
5
|
Overlapping outpatient visits
|
1.6915
|
1.6195
|
|
6
|
Overlapping clinical laboratory and physiological tests
|
1.7246
|
1.5868
|
|
7
|
Medical attendance
|
1.0931
|
1.6284
|
|
8
|
Generic drug rate index
|
1.0899
|
1.0257
|
|
Age
|
1.2097
|
1.3259
|
|
Sex
|
1.0077
|
1.0162
|
|
Follow-up period
|
1.4900
|
2.1885
|
|
ROC
|
|
AUC(95% CI)
|
0.880% (0.876–0.883)
|
0.896% (0.893–0.899)
|
- Abbreviations: VIF variance inflation factor, PDC proportion of days covered, ROC receiver operating characteristic curve, AUC area under the ROC curve, CI confidence interval
